🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/10/2019 | 81,43 | 82,78 | 80,60 | 82,14 | +0,58% | 2,68% | 514.400 |
| 17/10/2019 | 81,93 | 82,75 | 81,28 | 81,67 | -0,11% | 1,79% | 250.000 |
| 16/10/2019 | 82,19 | 84,06 | 81,07 | 81,76 | -0,26% | 3,64% | 416.700 |
| 15/10/2019 | 81,26 | 82,27 | 81,26 | 81,97 | +0,89% | 1,24% | 496.000 |
| 14/10/2019 | 81,59 | 82,41 | 80,82 | 81,25 | -0,78% | 1,95% | 313.700 |
| 11/10/2019 | 81,24 | 83,02 | 81,24 | 81,89 | +1,41% | 2,19% | 267.100 |
| 10/10/2019 | 80,11 | 81,37 | 79,45 | 80,75 | +1,30% | 2,40% | 318.000 |
| 09/10/2019 | 78,95 | 80,64 | 78,54 | 79,71 | +1,27% | 2,66% | 480.600 |
| 08/10/2019 | 79,60 | 80,05 | 78,16 | 78,71 | -1,55% | 2,37% | 344.000 |
| 07/10/2019 | 79,01 | 80,77 | 78,51 | 79,95 | +0,96% | 2,86% | 502.900 |
| 04/10/2019 | 78,45 | 79,46 | 76,33 | 79,19 | +1,12% | 3,99% | 473.900 |
| 03/10/2019 | 79,11 | 79,70 | 77,85 | 78,31 | -1,40% | 2,34% | 377.300 |
| 02/10/2019 | 78,03 | 79,80 | 77,30 | 79,42 | +1,35% | 3,20% | 668.200 |
| 01/10/2019 | 80,20 | 80,67 | 77,51 | 78,36 | -1,74% | 3,94% | 580.800 |
| 30/09/2019 | 80,84 | 81,11 | 78,45 | 79,75 | -1,35% | 3,29% | 552.200 |
| 27/09/2019 | 82,14 | 82,77 | 80,20 | 80,84 | -1,65% | 3,13% | 534.800 |
| 26/09/2019 | 85,15 | 85,15 | 81,76 | 82,20 | -3,29% | 3,98% | 476.800 |
| 25/09/2019 | 85,42 | 86,48 | 84,73 | 85,00 | -0,50% | 2,05% | 413.700 |
| 24/09/2019 | 85,53 | 85,87 | 84,53 | 85,43 | +0,41% | 1,57% | 594.000 |
| 23/09/2019 | 86,01 | 86,30 | 84,76 | 85,08 | -1,06% | 1,79% | 350.900 |
| 20/09/2019 | 86,49 | 87,08 | 84,77 | 85,99 | +0,08% | 2,67% | 714.300 |
| 19/09/2019 | 84,68 | 87,85 | 84,68 | 85,92 | +2,04% | 3,74% | 533.800 |
| 18/09/2019 | 86,11 | 86,35 | 83,70 | 84,20 | -1,94% | 3,08% | 443.100 |
| 17/09/2019 | 83,48 | 86,19 | 81,72 | 85,87 | +2,80% | 5,35% | 726.000 |
| 16/09/2019 | 80,55 | 83,89 | 79,71 | 83,53 | +3,52% | 5,19% | 424.600 |
| 13/09/2019 | 80,33 | 83,14 | 79,98 | 80,69 | +1,09% | 3,93% | 637.700 |
| 12/09/2019 | 83,02 | 83,48 | 79,26 | 79,82 | -3,74% | 5,08% | 480.700 |
| 11/09/2019 | 81,72 | 83,07 | 80,60 | 82,92 | +1,33% | 3,02% | 408.500 |
| 10/09/2019 | 79,89 | 81,90 | 78,97 | 81,83 | +2,16% | 3,67% | 526.800 |
| 09/09/2019 | 80,43 | 80,43 | 78,96 | 80,10 | -0,42% | 1,83% | 601.900 |